http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017236-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac191130d34b9194ac000628600006cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c808d03be8545c26cc0eb8890f8df65f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ddeb4949136193edc6cb8f29219b5ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e85e69471fa15f746a7748dba64dd3
publicationDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105017236-A
titleOfInvention C-aryl glycoside derivatives, their pharmaceutical composition, preparation method and application
abstract The present invention relates to C-aryl glycoside derivatives, their pharmaceutical composition, preparation method and application. The preparation method includes: Method 1: in a solvent, under the action of a base, compound 1-f is subjected to a deacetylation protecting group reaction; method 2: 1. Compound 2-g is mixed with Carry out the Mitsunobu reaction; 2. The compound 2-f obtained in step 1 is subjected to a deacetylation protecting group reaction; method three: 1. Compound 3-g and Mix to carry out a nucleophilic substitution reaction; 2. The compound 3-f obtained in step 1 is subjected to a deacetylation protecting group reaction. The pharmaceutical composition comprises: C-aryl glycoside derivatives, pharmaceutically acceptable salts and/or prodrugs thereof, and auxiliary materials. The present invention also relates to the application of C-aryl glycoside derivatives, their pharmaceutically acceptable salts or pharmaceutical compositions in the preparation of SGLT inhibitors. The C-aryl glycoside derivatives of the invention provide a new direction for the research of SGLT inhibitors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9914724-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112047915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988204-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112047915-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988204-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106928040-A
priorityDate 2014-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102643256-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102875503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105001213-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2795428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468004472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420656095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433511934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466653405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467473555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118462001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467473544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467473380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465564800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163844930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID184348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433512568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118461881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468031791

Total number of triples: 56.